SurvivorNet on MSN
A new all oral treatment for AML on the horizon for patients struggling to withstand chemo
Inqovi for AML treatment ...
Panelists discuss how the pathophysiology of acute myeloid leukemia has evolved from a single phenotype understanding to recognizing diverse genetic events that lead to transformation at the ...
Panelists discuss how the treatment landscape has evolved from limited options to include hypomethylating agents and venetoclax combinations, with emerging oral formulations promising greater ...
Moleculin Biotech ( (MBRX)) just unveiled an announcement. Moleculin Biotech has revealed promising findings showcasing Annamycin’s potential to combat acute myeloid leukemia (AML) resistant to ...
CLN-049 monotherapy demonstrates promising efficacy, including multiple complete responses and encouraging response durability, in a heavily pretreated all-comer population of patients with R/R AML 31 ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Given the biological complexity of acute ...
Ligufalimab targets CD47, enhancing macrophage-mediated cancer cell destruction, and avoids red blood cell clumping, improving safety and efficacy. Early trials show ligufalimab, combined with Vidaza ...
AUSTIN, TX and DURHAM, NC, June 10, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new ...
Relapsed acute myeloid leukemia (AML) is when cancer returns after a period of remission. Refractory AML means cancer has not responded to multiple rounds of treatment. Both can affect your treatment ...
Discover the challenges of acute myeloid leukaemia linked to inflammatory cell death and the quest for effective therapies.
With a new four-year, $1.3 million grant from the U.S. Department of Veterans Affairs, researchers at Case Western Reserve University are investigating a new approach to treat Acute Myeloid Leukemia ...
NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The acute myeloid leukemia (AML) treatment market in APAC size is estimated to grow by USD 305.8 million from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results